Order Code MBLF Mannan Binding Lectin Complement Pathway, Functional, Serum
Ordering Guidance
The most appropriate primary assays to use as screening methods for complement deficiencies are COM / Complement, Total, Serum and AH50 / Alternative Complement Pathway, Functional, Serum. Abnormal results in one or the other, none, or both assays will help direct further testing. If total complement and AH50 are both normal but the suspicion of a complement deficiency remains, this test for the lectin pathway function is recommended. After the initial 3 pathways of complement functional status are evaluated, the analysis of individual components and regulators may uncover functional or quantitative defects in certain components.
This test is rarely useful when ordered in isolation.
As the heat-labile fraction of the immune system, complement activation in vitro has been a challenge for researchers and scientists. Because of the thermal instability of complement proteins, it is often necessary to repeat testing to rule out a possible pre-analytical issue with a sample type, real complement consumption, or dysregulation.
Specimen Required
Patient Preparation:
1. Specimen should not be collected earlier than 48 hours following plasma exchange.
2. Fasting is preferred.
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube: Red top (serum gel/SST are not acceptable)
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions:
1. Immediately after specimen collection, place the tube on wet ice.
2. After sample has clotted on wet ice, centrifuge at 4° C and aliquot serum into plastic vial.
3. Freeze specimen within 30 minutes of centrifugation. Sample must be placed on dry ice if not frozen immediately.
Additional Information:
If a refrigerated centrifuge is not available, it is acceptable to use a room temperature centrifuge, provided the specimen is kept on ice before centrifugation, and immediately afterward, the serum aliquoted and frozen.
Useful For
Investigating recurrent meningococcal disease in young children
Investigating recurrent or severe infections in adults
Investigating glomerular kidney diseases
Additionally, deficiencies or dysregulation within the complement system may be identified in patients when this test is used in combination with related tests.
Method Name
Enzyme-Linked Immunosorbent Assay (ELISA)
Reporting Name
MBL Complement Path, Func, SSpecimen Type
Serum RedSpecimen Minimum Volume
0.4 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum Red | Frozen | 14 days |
Reject Due To
Gross hemolysis | OK |
Gross lipemia | OK |
Gross icterus | OK |
Reference Values
≥10%
Method Description
The Wieslab enzyme-linked immunosorbent assay complement assay for the mannan-binding lectin (MBL) pathway combines principles of the hemolytic assay for complement activation with the use of labeled antibodies specific for neoantigens produced as a result of complement activation. The micro titer plate strips are coated with mannan. Patient serum is diluted in diluent containing specific blocker to ensure that only the MBL pathway is activated. During the first incubation, the diluted patient serum in the wells is activated by the coating. The wells are then washed and C5b-9 membrane attack complex (MAC) is detected with a specific alkaline phosphatase labeled antibody to the neoantigen expressed during MAC formation. After a final wash, an alkaline phosphatase substrate is added. The amount of MBL pathway complement activity correlates with the color intensity of the solution and is measured by absorbance (optical density).(Mollnes TE, Jokiranta TS, Truedsson L, et al. Complement analysis in the 21st century. Mol Immunol. 2007;44[16]:3838-49; Willrich MAV, Braun KMP, Moyer AM, Jeffrey DH, Frazer-Abel A. Complement testing in the clinical laboratory. Crit Rev Clin Lab Sci. 2021:1-51)
Day(s) Performed
Wednesday
Performing Laboratory
Mayo Clinic Laboratories in RochesterCPT Code Information
86161